<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Updates From 2022 SABCS Underscore the Continued Expansion of Treatment Options in Metastatic Breast Cancer

Written by OncLive on January 18, 2023

The 2022 San Antonio Breast Cancer Symposium highlighted research and treatments for HER2-negative, HER2-low, and HER2-positive breast cancer.

Topics: Press Coverage

Comments

Related Stories